Thomas Ciulla MD PC

[ad_1] Congrats to colleagues & partners with numerous presentations involving #suprachoroidal delivery at last week’s @OISTWEETS & #ASRS meetings! In addition to FDA-approved #Xipere, 6 trials globally are assessing 4 different investigational therapies, using the SCS Microinjector. https://t.co/g8QZgV3Fp0 [ad_2] Source by Thomas Ciulla, MD, MBA …

[ad_1] RT @ModernRetina: WATCH: Charles Wykoff, MD, discusses, “Suprachoroidal Delivery of RGX-314 Gene Therapy for Diabetic Retinopathy: Phase II… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @ThomasCiullaMD: Congrats to colleagues & partners with numerous presentations involving #suprachoroidal delivery at last week’s #OIS &… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Suprachoroidal triamcinolone acetonide injectable suspension for macular edema associated with uveitis: Outcomes by anatomic subtypes in PEACHTREE | IOVS | ARVO Journals https://t.co/t6aafCaHqi [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] RT @BauschLomb: At the @asrsdocs annual meeting this week, five presentations will highlight data from the XIPERE® (triamcinolone acetonide… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

[ad_1] Congrats to colleagues & partners with numerous presentations involving #suprachoroidal delivery at last week’s #OIS & #ASRS meetings! In addition to FDA-approved #Xipere, 6 trials globally are assessing 4 different investigational therapies, using the SCS Microinjector. https://t.co/5ryJlrkxow [ad_2] Source by Thomas Ciulla, MD, MBA …

[ad_1] Dr Steven Yeh on Patients Treated With Xipere and Its Use Over the Long Term https://t.co/nWhm7CUCJP via @AJMC_Journal [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.